
The FDA temporarily suspended its ban on sales of the popular e-cigarette maker Juul, backed by Altria Group Inc (NYSE:MO), which owns a 35% stake in the company.
“On July 5, 2022, FDA administratively stayed the marketing denial order,” the agency’s tobacco division wrote in a tweet. “The agency has determined that there are scientific issues unique to the JUUL application that warrant additional review.”